Nonsteroidal anti-inflammatory drug-activated gene-1 (NAG-1), a member of the transforming growth factor β (TGF-β) superfamily, has been demonstrated to possess antitumorigenic and proapoptotic activities in gastric cancer cells. Here, TGFB1 is linked to gastric cancer.